Prudential Financial Inc. Sells 39,360 Shares of Oscar Health, Inc. $OSCR

Prudential Financial Inc. lessened its holdings in Oscar Health, Inc. (NYSE:OSCR) by 33.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 79,960 shares of the company’s stock after selling 39,360 shares during the period. Prudential Financial Inc.’s holdings in Oscar Health were worth $1,714,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in OSCR. LRI Investments LLC boosted its position in shares of Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after acquiring an additional 975 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio acquired a new stake in Oscar Health during the first quarter valued at approximately $30,000. Atlantic Union Bankshares Corp acquired a new stake in Oscar Health during the second quarter valued at approximately $33,000. Finally, Caitong International Asset Management Co. Ltd grew its stake in shares of Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after purchasing an additional 2,854 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. Wall Street Zen cut Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Finally, UBS Group lifted their price target on shares of Oscar Health from $11.00 to $12.00 and gave the company a “sell” rating in a report on Friday, November 7th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Reduce” and a consensus price target of $14.86.

Insider Activity at Oscar Health

In related news, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the transaction, the insider owned 172,527 shares in the company, valued at $2,862,222.93. The trade was a 4.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the transaction, the insider directly owned 501,148 shares in the company, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 739,472 shares of company stock valued at $12,616,880 over the last ninety days. Company insiders own 24.39% of the company’s stock.

Oscar Health Price Performance

Shares of OSCR stock opened at $16.77 on Friday. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80. The stock has a market capitalization of $4.44 billion, a PE ratio of -14.97 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The stock’s fifty day moving average is $18.03 and its 200-day moving average is $16.94.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same period in the previous year, the business posted ($0.22) earnings per share. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. Equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.